These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 9480488

  • 1. [Diffuse interstitial lung disease without pleural involvement and high-dose bromocriptine].
    Marsaudon E, Castet D, Barrault MF, Allais C.
    Rev Mal Respir; 1997 Nov; 14(5):405-7. PubMed ID: 9480488
    [Abstract] [Full Text] [Related]

  • 2. [Pleural effusion induced by bromocriptine].
    Diot E, Diot P, Le Rolland A, Jonville AP, Lasfargues G, Lemarie E, Lavandier M, Guilmot JL.
    Rev Mal Respir; 1990 Nov; 7(2):175-7. PubMed ID: 2320790
    [Abstract] [Full Text] [Related]

  • 3. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
    Debove P, Simon F, Vaylet F, Renard JL, L'Her P.
    Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541
    [Abstract] [Full Text] [Related]

  • 4. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
    McElvaney NG, Wilcox PG, Churg A, Fleetham JA.
    Arch Intern Med; 1988 Oct; 148(10):2231-6. PubMed ID: 3178380
    [Abstract] [Full Text] [Related]

  • 5. Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.
    Hillerdal G, Lee J, Blomkvist A, Rask-Andersen A, Uddenfeldt M, Koyi H, Rasmussen E.
    Eur Respir J; 1997 Dec; 10(12):2711-5. PubMed ID: 9493648
    [Abstract] [Full Text] [Related]

  • 6. [Pleural effusion and severe edema of the lower limbs induced by bromocriptine].
    Messiaen T, Lefebvre C, Weynand B, Pieters T.
    Rev Med Interne; 1996 Dec; 17(8):680-3. PubMed ID: 8881198
    [Abstract] [Full Text] [Related]

  • 7. Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
    Champagne S, Coste E, Peyrière H, Nigond J, Mania E, Pons M, Hillaire-Buys D, Balmes P, Blayac JP, Davy JM.
    Ann Pharmacother; 1999 Oct; 33(10):1050-4. PubMed ID: 10534217
    [Abstract] [Full Text] [Related]

  • 8. Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
    Knoop C, Mairesse M, Lenclud C, Gevenois PA, De Vuyst P.
    Eur Respir J; 1997 Dec; 10(12):2898-901. PubMed ID: 9493681
    [Abstract] [Full Text] [Related]

  • 9. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity].
    Douvier JJ, Vergeret J, Taytard A, Brottier E, Domblides P, Dubos F, Freour P.
    Ann Med Interne (Paris); 1985 Dec; 136(5):416-8. PubMed ID: 4062141
    [Abstract] [Full Text] [Related]

  • 10. Suggestive evidence for bromocriptine-induced pleurisy.
    Klaassen RJ, Troost RJ, Verhoeven GT, Krepel HP, van der Lely AJ.
    Neth J Med; 1996 Jun; 48(6):232-6. PubMed ID: 8710045
    [Abstract] [Full Text] [Related]

  • 11. [Bromocriptine-induced pleuropneumopathy].
    Schmid PA, Suter T, Speich R, Eberli F, Greminger P.
    Dtsch Med Wochenschr; 1994 Nov 11; 119(45):1543-6. PubMed ID: 7956789
    [Abstract] [Full Text] [Related]

  • 12. [Severe pleuropericarditis induced by long-term bromocriptin therapy, report of a case and review of the literature].
    Ciubotaru V, Poinsignon Y, Brunet-Bourgin F, Mestassi M, Rosenbaum D.
    Rev Med Interne; 2004 Apr 11; 25(4):310-4. PubMed ID: 15050800
    [Abstract] [Full Text] [Related]

  • 13. Pleuropulmonary involvement during bromocriptine treatment.
    Kinnunen E, Viljanen A.
    Chest; 1988 Nov 11; 94(5):1034-6. PubMed ID: 3180854
    [Abstract] [Full Text] [Related]

  • 14. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
    Salaffi F, Carotti M, Baldelli S, Bichi Secchi E, Manganelli P, Subiaco S, Salvolini L.
    Radiol Med; 1999 Nov 11; 97(1-2):33-41. PubMed ID: 10319097
    [Abstract] [Full Text] [Related]

  • 15. [Interstitial lung disease linked to fluoxetine].
    Vandezande LM, Lamblin C, Wallaert B.
    Rev Mal Respir; 1997 Sep 11; 14(4):327-9. PubMed ID: 9411618
    [Abstract] [Full Text] [Related]

  • 16. [Cyclophosphamide-induced interstitial pneumopathy. Course data of bronchoalveolar lavage apropos of a case and review of the literature].
    Cuguillière A, Bérard H, N'Guyen G, Miltgen J, Martet G, Eskandari J, Bonnet D.
    Rev Pneumol Clin; 1999 Apr 11; 55(2):100-4. PubMed ID: 10418054
    [Abstract] [Full Text] [Related]

  • 17. Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
    Malik SW, Myers JL, DeRemee RA, Specks U.
    Am J Respir Crit Care Med; 1996 Dec 11; 154(6 Pt 1):1851-6. PubMed ID: 8970380
    [Abstract] [Full Text] [Related]

  • 18. Low dose cabergoline induced interstitial pneumonitis.
    Frank W, Moritz R, Becke B, Pauli R.
    Eur Respir J; 1999 Oct 11; 14(4):968-70. PubMed ID: 10573251
    [Abstract] [Full Text] [Related]

  • 19. [Pleuropulmonary fibrosis and bromocriptine].
    Vergeret J, Barat M, Taytard A, Bellvert P, Domblides P, Douvier JJ, Fréour P.
    Sem Hop; 1984 Mar 08; 60(11):741-4. PubMed ID: 6324351
    [Abstract] [Full Text] [Related]

  • 20. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL, Schmitt L, Bagheri H.
    Rev Neurol (Paris); 2003 Apr 08; 159(4):441-3. PubMed ID: 12773874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.